President Donald Trump praised the CDC panel’s vote to lift universal Hepatitis B shots, sparking warnings from health experts

A vaccine advisory panel on Friday voted to end its recommendation that kids receive hepatitis B vaccine at birth.

The change represents a continued shift in the agency’s vaccine policy, reflecting increasingly skeptical views.

Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the childhood vaccine schedule, potentially delaying a dose of the hepatitis B vaccine given to newborns by weeks or even years.

The new chair of the Advisory Committee on Immunization Practices said the panel plans to vote to end universal hepatitis B vaccination at birth and to scrutinize if childhood shots cause allergies.

A panel of US vaccine advisers voted to rescind a recommendation that all newborns should receive a hepatitis B vaccine at birth.

The health secretary has walled himself off from government scientists and empowered fellow activists to pursue his vaccine agenda.

U.S. health authorities are considering how they might discourage or even ban vaccines that rely on a common ingredient to boost their effectiveness